BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25789847)

  • 21. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.
    Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH
    Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines.
    Brandi G; Paiardini M; Cervasi B; Fiorucci C; Filippone P; De Marco C; Zaffaroni N; Magnani M
    Cancer Res; 2003 Jul; 63(14):4028-36. PubMed ID: 12874002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein.
    Hsu JC; Dev A; Wing A; Brew CT; Bjeldanes LF; Firestone GL
    Biochem Pharmacol; 2006 Dec; 72(12):1714-23. PubMed ID: 16970927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
    Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
    Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-34a is essential for p19(Arf)-driven cell cycle arrest.
    Iqbal N; Mei J; Liu J; Skapek SX
    Cell Cycle; 2014; 13(5):792-800. PubMed ID: 24401748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
    Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
    Do MT; Kim HG; Choi JH; Jeong HG
    Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.
    Irani S; Paknejad M; Soleimani M; Azam S
    Iran Biomed J; 2020 Nov; 24(6):361-9. PubMed ID: 32660221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in Breast Cancer Cells.
    El-Daly SM; Gamal-Eldeen AM; Gouhar SA; Abo-Elfadl MT; El-Saeed G
    Appl Biochem Biotechnol; 2020 Dec; 192(4):1208-1223. PubMed ID: 32710170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy.
    Mohammady M; Ghetmiri SI; Baharizade M; Morowvat MH; Torabi S
    Curr Pharm Biotechnol; 2019; 20(8):665-673. PubMed ID: 31244419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The p53/miR-34a/SIRT1 Positive Feedback Loop in Quercetin-Induced Apoptosis.
    Lou G; Liu Y; Wu S; Xue J; Yang F; Fu H; Zheng M; Chen Z
    Cell Physiol Biochem; 2015; 35(6):2192-202. PubMed ID: 25896587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.
    Li L; Yuan L; Luo J; Gao J; Guo J; Xie X
    Clin Exp Med; 2013 May; 13(2):109-17. PubMed ID: 22623155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.
    De Santi M; Galluzzi L; Lucarini S; Paoletti MF; Fraternale A; Duranti A; De Marco C; Fanelli M; Zaffaroni N; Brandi G; Magnani M
    Breast Cancer Res; 2011 Mar; 13(2):R33. PubMed ID: 21435243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells.
    Safa M; Tavasoli B; Manafi R; Kiani F; Kashiri M; Ebrahimi S; Kazemi A
    Tumour Biol; 2015 May; 36(5):3919-30. PubMed ID: 25589462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Alkoxy derivatization of indole-3-carbinol increases the efficacy of the G1 cell cycle arrest and of I3C-specific regulation of cell cycle gene transcription and activity in human breast cancer cells.
    Jump SM; Kung J; Staub R; Kinseth MA; Cram EJ; Yudina LN; Preobrazhenskaya MN; Bjeldanes LF; Firestone GL
    Biochem Pharmacol; 2008 Feb; 75(3):713-24. PubMed ID: 18023427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis.
    Sharula ; Wu Z
    Anticancer Agents Med Chem; 2017; 17(7):941-947. PubMed ID: 28356025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.
    Nguyen HH; Lavrenov SN; Sundar SN; Nguyen DH; Tseng M; Marconett CN; Kung J; Staub RE; Preobrazhenskaya MN; Bjeldanes LF; Firestone GL
    Chem Biol Interact; 2010 Aug; 186(3):255-66. PubMed ID: 20570586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
    Tin AS; Sundar SN; Tran KQ; Park AH; Poindexter KM; Firestone GL
    Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance.
    Ahmed F; Ijaz B; Ahmad Z; Farooq N; Sarwar MB; Husnain T
    Phytomedicine; 2020 Mar; 68():153168. PubMed ID: 31982837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.